Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1458 | 7777 | 49.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
268 | 3 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 44049 |
1458 | 2 | SEMAPHORIN//EPHRIN//AXON GUIDANCE | 7777 |
2660 | 1 | EPHRIN//EPH//EPH RECEPTOR | 2182 |
3793 | 1 | NETRIN 1//NETRIN//ROBO | 1906 |
4557 | 1 | SEMAPHORIN//PLEXIN//NEUROPILIN | 1767 |
8136 | 1 | GROWTH CONE//NEURONAL POLARITY//FILOPODIA | 1288 |
22868 | 1 | CRMP2//COLLAPSIN RESPONSE MEDIATOR PROTEIN//CRMP | 366 |
25907 | 1 | AMINOETHYLCYSTEINE KETIMINE DECARBOXYLATED DIMER//LANCL2//THIALYSINE | 268 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SEMAPHORIN | authKW | 1142099 | 5% | 78% | 373 |
2 | EPHRIN | authKW | 1072673 | 5% | 75% | 366 |
3 | AXON GUIDANCE | authKW | 937166 | 7% | 43% | 555 |
4 | PLEXIN | authKW | 577956 | 2% | 91% | 161 |
5 | EPH | authKW | 523901 | 2% | 82% | 163 |
6 | NEUROPILIN | authKW | 493807 | 2% | 68% | 184 |
7 | EPH RECEPTOR | authKW | 486255 | 2% | 82% | 151 |
8 | NETRIN 1 | authKW | 398898 | 2% | 76% | 133 |
9 | GROWTH CONE | authKW | 395636 | 4% | 33% | 308 |
10 | NETRIN | authKW | 374079 | 2% | 73% | 131 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Developmental Biology | 27835 | 12% | 1% | 956 |
2 | Neurosciences | 21463 | 32% | 0% | 2463 |
3 | Cell Biology | 15952 | 24% | 0% | 1889 |
4 | Biochemistry & Molecular Biology | 3997 | 22% | 0% | 1738 |
5 | Oncology | 2859 | 12% | 0% | 921 |
6 | Anatomy & Morphology | 590 | 1% | 0% | 107 |
7 | Biophysics | 541 | 4% | 0% | 323 |
8 | Genetics & Heredity | 460 | 5% | 0% | 364 |
9 | Medicine, Research & Experimental | 226 | 3% | 0% | 253 |
10 | Pathology | 141 | 2% | 0% | 151 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL PHARMACOL NEUROBIOL | 135020 | 1% | 54% | 64 |
2 | OPTOSIS CANC DEV EQUIPE ELLISEE LA LIG | 40362 | 0% | 86% | 12 |
3 | NEURONAL GROWTH MECH | 37381 | 0% | 53% | 18 |
4 | KENT WALDREP BASIC NERVE GROWTH REGENER | 35867 | 0% | 57% | 16 |
5 | OPTOSIS CANC DEV | 34629 | 0% | 55% | 16 |
6 | GRP DEV NEUROBIOLCHIKUSA KU | 28026 | 0% | 71% | 10 |
7 | PAUL CAROLE STARK NEUROSCI | 26420 | 0% | 42% | 16 |
8 | MICROSCOPY CYTOMETRY | 25113 | 0% | 80% | 8 |
9 | EXPT NEUROTHER EUT | 24520 | 0% | 63% | 10 |
10 | DEV NEUROBIOL | 20222 | 1% | 5% | 112 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEURON | 25352 | 3% | 3% | 231 |
2 | DEVELOPMENTAL NEUROBIOLOGY | 20070 | 1% | 7% | 70 |
3 | JOURNAL OF NEUROSCIENCE | 18931 | 5% | 1% | 409 |
4 | CELL ADHESION & MIGRATION | 17267 | 1% | 9% | 51 |
5 | KEIO UNIVERSITY SYMPOSIA FOR LIFE SCIENCE AND MEDICINE | 15700 | 0% | 11% | 35 |
6 | MOLECULAR AND CELLULAR NEUROSCIENCE | 14196 | 1% | 4% | 101 |
7 | JOURNAL OF NEUROBIOLOGY | 13657 | 1% | 4% | 94 |
8 | DEVELOPMENT | 12471 | 3% | 2% | 203 |
9 | DEVELOPMENTAL BIOLOGY | 5535 | 2% | 1% | 142 |
10 | CURRENT OPINION IN NEUROBIOLOGY | 4746 | 1% | 2% | 54 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SEMAPHORIN | 1142099 | 5% | 78% | 373 | Search SEMAPHORIN | Search SEMAPHORIN |
2 | EPHRIN | 1072673 | 5% | 75% | 366 | Search EPHRIN | Search EPHRIN |
3 | AXON GUIDANCE | 937166 | 7% | 43% | 555 | Search AXON+GUIDANCE | Search AXON+GUIDANCE |
4 | PLEXIN | 577956 | 2% | 91% | 161 | Search PLEXIN | Search PLEXIN |
5 | EPH | 523901 | 2% | 82% | 163 | Search EPH | Search EPH |
6 | NEUROPILIN | 493807 | 2% | 68% | 184 | Search NEUROPILIN | Search NEUROPILIN |
7 | EPH RECEPTOR | 486255 | 2% | 82% | 151 | Search EPH+RECEPTOR | Search EPH+RECEPTOR |
8 | NETRIN 1 | 398898 | 2% | 76% | 133 | Search NETRIN+1 | Search NETRIN+1 |
9 | GROWTH CONE | 395636 | 4% | 33% | 308 | Search GROWTH+CONE | Search GROWTH+CONE |
10 | NETRIN | 374079 | 2% | 73% | 131 | Search NETRIN | Search NETRIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BOYD, AW , BARTLETT, PF , LACKMANN, M , (2014) THERAPEUTIC TARGETING OF EPH RECEPTORS AND THEIR LIGANDS.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 1. P. 39-62 | 252 | 85% | 76 |
2 | NIEVERGALL, E , LACKMANN, M , JANES, PW , (2012) EPH-DEPENDENT CELL-CELL ADHESION AND SEGREGATION IN DEVELOPMENT AND CANCER.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 69. ISSUE 11. P. 1813-1842 | 308 | 84% | 29 |
3 | HOTA, PK , BUCK, M , (2012) PLEXIN STRUCTURES ARE COMING: OPPORTUNITIES FOR MULTILEVEL INVESTIGATIONS OF SEMAPHORIN GUIDANCE RECEPTORS, THEIR CELL SIGNALING MECHANISMS, AND FUNCTIONS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 69. ISSUE 22. P. 3765-3805 | 322 | 67% | 48 |
4 | PASQUALE, EB , (2010) EPH RECEPTORS AND EPHRINS IN CANCER: BIDIRECTIONAL SIGNALLING AND BEYOND.NATURE REVIEWS CANCER. VOL. 10. ISSUE 3. P. 165 -180 | 173 | 78% | 419 |
5 | WORZFELD, T , OFFERMANNS, S , (2014) SEMAPHORINS AND PLEXINS AS THERAPEUTIC TARGETS.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 8. P. 603 -621 | 177 | 93% | 35 |
6 | NASARRE, P , GEMMILL, RM , DRABKIN, HA , (2014) THE EMERGING ROLE OF CLASS-3 SEMAPHORINS AND THEIR NEUROPILIN RECEPTORS IN ONCOLOGY.ONCOTARGETS AND THERAPY. VOL. 7. ISSUE . P. 1663 -1687 | 222 | 74% | 14 |
7 | YAZDANI, U , TERMAN, JR , (2006) THE SEMAPHORINS.GENOME BIOLOGY. VOL. 7. ISSUE 3. P. - | 184 | 91% | 192 |
8 | GUCCIARDO, E , SUGIYAMA, N , LEHTI, K , (2014) EPH- AND EPHRIN-DEPENDENT MECHANISMS IN TUMOR AND STEM CELL DYNAMICS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 71. ISSUE 19. P. 3685 -3710 | 209 | 76% | 16 |
9 | NEUFELD, G , MUMBLAT, Y , SMOLKIN, T , TOLEDANO, S , NIR-ZVI, I , ZIV, K , KESSLER, O , (2016) THE ROLE OF THE SEMAPHORINS IN CANCER.CELL ADHESION & MIGRATION. VOL. 10. ISSUE 6. P. 652 -674 | 201 | 81% | 0 |
10 | XI, HQ , WU, XS , WEI, B , CHEN, L , (2012) EPH RECEPTORS AND EPHRINS AS TARGETS FOR CANCER THERAPY.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. VOL. 16. ISSUE 12. P. 2894-2909 | 173 | 88% | 30 |
Classes with closest relation at Level 2 |